Disclosure Of Entity's Operating Segments [Text Block]

Alligator Bioscience - Filing #703046

Concept As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
Disclosure of entity's operating segments [text block]
Disclosure of operating segments [text block]
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Depreciation and amortisation expense
11 144 SEK
11 522 SEK
Tax expense (income)
- SEK
- SEK
Profit (loss) before tax
141 736 SEK
143 296 SEK
Profit (loss)
141 736 SEK
141 736 SEK
143 296 SEK
143 296 SEK
Assets
333 200 SEK
151 938 SEK
Cash flows from (used in) operating activities
127 033 SEK
141 352 SEK
Cash flows from (used in) investing activities
45,000 SEK
156 886 SEK
Cash flows from (used in) financing activities
301 795 SEK
6 148 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.